Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 6, 2000, Pages 1600-1605

  Gnasso, Agostino ^a   Motti, Corradino ^b   Irace, Concetta ^a   Carallo, Claudio ^a   Liberatoscioli, Laura ^d   Bernardini, Sergio ^d   Massoud, Renato ^d   Mattioli, Pier Luigi ^a   Federici, Giorgio ^c   Cortese, Claudio ^d  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF TERAMO   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Atherosclerosis; Carotid arteries; Metalloproteinases; Polymerase chain reaction; Ultrasonics

Indexed keywords

METALLOPROTEINASE; STROMELYSIN;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; BODY MASS; COMMON CAROTID ARTERY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SHEAR STRESS; TRANSCRIPTION REGULATION;

EID: 20244378501     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.6.1600     Document Type: Article

References (38)

1. Birkedal-Hansen H, Moore W, Bodden MK, Windsor U, Birkedan-Hansen B, De Carlo A, Engler JA. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4:197-250.
2. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990;6:121-125.
3. Quinones S, Buttice G, Kurkinen M. Promoter elements in the transcriptional activation of the human stromelysin-1 gene by the inflammatory cytokine, interleukin 1. Biochem J. 1994;302:471-477.
4. Galis ZS, Muszynski M, Sukova GK, Simon-Morrissey E, Libby P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci. 1995;748:501-507.
5. Diaz-Meco MT, Quinones S, Municio MM, Sanz L, Bernai D, Cabrero E, Saus J, Moscat J. Protein kinase C-independent expression of stromelysin by platelet-derived growth factor, ras oncogene, and phosphatidylcholine-hydrolyzing phospholipase C. J Biol Chem. 1991;266:22597-22602.
6. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J. 1995;73: 209-215.
7. Ye S, Eriksson P, Hamsten A, Kirkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem. 1996;271:13055-13060.
8. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S. Localization of stromelysin gene expression in atherosclerotic plaque by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88:8154-8158.
9. Galis ZS, Sukhova GK, Lark M, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
10. Shab PK, Falk E, Badimon JJ, Fernandez-Oriz A, Maihac A, Villareal-Levy G, Fallon JT, Rengstrom J, Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 1995;92: 1585-1589.
11. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A. 1995;92:402-406.
12. Libby P, Geng YJ, Aikawa M, Schonbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT. Macrophage and atherosclerosis plaque stability. Curr Opin Lipidol. 1996;7:330-335.
13. Cowan DB, Langille BL. Cellular and molecular biology of vascular remodeling. Curr Opin Lipidol. 1996;7:94-100.
14. Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow effects on prostacyclin production by cultured human endothelial cells. Science. 1985; 227:1477-1479.
15. Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest. 1991;88:1663-1671.
16. Noris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini M, Orisio S, Remuzzi G, Remuzzi A. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res. 1995;76: 536-543.
17. Kamiya A, Togawa T. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol. 1980;239:H14-H21.
18. Girerd X, London G, Boutouyrie P, Mourad JJ, Safar M, Laurent S. Remodeling of the radial artery in response to a chronic increase in shear stress. Hypertension. 1996;27:799-803.
19. Ben Driss A, Benessiano J, Poitevin P, Levy BI, Michel JB. Arterial expansive remodeling induced by high flow rates. Am J Physiol. 1997; 272:H851-H858.
20. Gnasso A, Carallo C, Irace C, Spagnuolo V, De Novara G, Mattioli PL, Pujia A. Association between intima-media thickness and wall shear stress in the common carotid arteries in healthy male subjects. Circulation. 1996;94:3257-3262.
21. Quinones S, Saus J, Otani Y, Harris ED, Kurkinen M. Transcriptional regulation of human stromelysin. J Biol Chem. 1989;264:8339-8344.
22. Motti C, Gnasso A, Bernardini S, Massoud R, Pastore A, Rampa P, Federici G, Cortese C. Common mutation in methylenetetrahydrofolate reductase: correlation with homocysteine and other risk factors for vascular disease. Atherosclerosis. 1998;139:377-383.
23. Steinke W, Els T, Hennerici M. Compensatory carotid artery dilation in atherosclerosis. Circulation. 1994;89:2578-2581.
24. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375.
25. Polak JF, Kronmal RA, Tell GS, O'Leary DH, Savage PJ, Gardin JM, Rutan GH, Borhani NO, on behalf of the Cardiovascular Health Study. Compensatory increase in common carotid artery diameter: relation to blood pressure and artery intima-media thickness in older adults. Stroke. 1996;27:2012-2015.
26. Crouse JR, Goldbourt U, Evans G, Pinsky J, Sharrett AR, Sorlie P, Riley W, Heiss G, for the ARIC Investigators. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1996;27:69-75.
27. Bonithon-Kopp C, Touboul PJ, Berr C, Magne C, Ducimetière P. Factors of carotid arterial enlargement in a population aged 59 to 71 years: the EVA Study. Stroke. 1996;27:654-660.
28. Irace C, Carallo C, Crescenzo A, Motti C, De Franceschi MS, Mattioli PL, Gnasso A. NIDDM is associated with lower wall shear stress of the common carotid artery. Diabetes. 1999;48:193-197.
29. Gnasso A, Irace C, Carallo C, De Franceschi MS, Motti C, Mattioli PL, Pujia A. In vivo association between low wall shear stress and plaque in subjects with asymmetrical carotid atherosclerosis. Stroke. 1997;28: 993-998.
30. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, for the Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14-22.
31. de Maat MPM, Jukema W, Ye S, Zwinderman AH, Moghaddam PH, Beekman M, Kastelein JJP, van Boven AJ, Bruschke AVG, Humphries SE, Kluft C, Henney AM. Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis. Am J Cardiol. 1999;83:852-856.
32. Humphries SE, Luong LA, Talmud PJ, Frick MH, Kesäniemi YA, Pasternack A, Taskinen MR, Syvänne M. The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Atherosclerosis. 1998;139:49-56.
33. Zucker S, Hymowitz M, Conner C, Zarrabi HM, Hurewitz AN, Matrisian L, Boyd D, Nicolson G, Montana S. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Ann N Y Acad Sci. 1999;878:212-227.
34. Moscatelli D, Rifkin DB. Membrane and matrix localization of proteinases: a common theme in tumor invasion and angiogenesis. Biochim Biophys Acta. 1988;948:67-84.
35. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
36. Terashima M, Akita H, Kanazawa K, Inoue N, Yamada S, Ito K, Matsuda Y, Takai E, Iwai C, Kurogane H, Yoshida Y, Yokoyama M. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation. 1999;99:2717-2719.
37. Falk E, Shah PK, Fuster V. Pathogenesis of plaque disruption. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa: Lippincott-Raven; 1996;2:492-510.
38. Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis. 1995; 116:43-57.